The medical model in psychology treats mental health conditions the same way medicine treats physical diseases: as problems rooted in biology that can be diagnosed, categorized, and treated with physical interventions. Under this framework, experiences like hallucinations, persistent sadness, or panic attacks are viewed as symptoms of an underlying physiological problem, much like a fever signals an infection. It remains one of the most influential approaches in mental health care, shaping how conditions are classified, how treatments are chosen, and how insurance systems process claims.
How the Medical Model Works
The core logic is straightforward. Health is defined as the absence of disease, and disease is defined as the body deviating from normal physical functioning. When someone presents with psychological distress, the model assumes a biological cause exists, even if it hasn’t been fully identified yet. The clinician’s job is to identify the underlying disorder, give it a name, and select a treatment that targets the biology.
This plays out in four steps. First, symptoms are described and grouped together into recognizable patterns. Second, a biological cause or contributing factor is proposed. Third, a treatment is selected to correct or manage that biological factor, most often medication. Fourth, a prognosis is offered based on how similar cases typically progress over time. The entire structure mirrors what happens when you visit a doctor for chest pain or a skin rash.
The Biological Factors It Emphasizes
The medical model points to several categories of biological explanation for mental health conditions. Genetics is a major one. Twin studies estimate that schizophrenia, bipolar disorder, and autism spectrum disorder are 60 to 80 percent heritable, while PTSD is estimated at 30 to 50 percent heritable among people who have experienced trauma. Several hundred gene locations have already been implicated in schizophrenia alone.
Neurotransmitter activity is another key focus. For decades, the model has linked depression to disruptions in serotonin signaling and schizophrenia to dopamine irregularities, though the picture has grown more complex over time. Research from Harvard Medical School has found that energy production in the brains of people with schizophrenia and bipolar disorder is roughly 22 percent slower than in healthy brains, generating excess oxidative stress molecules in the process. That kind of metabolic finding fits neatly into the medical model’s framework: a measurable biological deviation that could explain symptoms.
Structural brain differences also matter here. One line of research identified a gene called C4 that, in certain variants, produces elevated levels of a protein involved in synaptic pruning, the process by which the brain eliminates connections between neurons. People with schizophrenia carry these variants more often, which may help explain why brain imaging shows thinner tissue in the prefrontal cortex of people with the condition. That region governs executive function, social behavior, emotional response, and personality expression.
More recent work has expanded the biological lens further. Immune system activity, gut bacteria, and even inherited stress responses are now under investigation. In animal studies, provoking immune responses in pregnant mice altered brain structure in their offspring in ways that resemble changes seen in autistic children. Separately, mice that experienced repeated mild shocks paired with a scent passed fear responses to that scent down to their offspring and even their offspring’s offspring, along with structural changes in brain regions involved in processing smell.
The DSM: The Model’s Diagnostic Backbone
The most visible product of the medical model in psychology is the Diagnostic and Statistical Manual of Mental Disorders, now in its fifth edition (DSM-5). This reference book provides detailed definitions of mental health conditions, organizes them into groups, and assigns diagnostic codes that link to the World Health Organization’s international classification system. It is the standard reference clinicians use to distinguish one condition from another when symptoms overlap.
The DSM’s structure reflects the medical model’s assumptions. Conditions are treated as discrete categories, each with specific criteria that must be met for a diagnosis. A person either qualifies for major depressive disorder or they don’t, much like a lab test confirms or rules out diabetes. This categorical approach makes communication between providers more consistent and enables large-scale research, since researchers worldwide can use the same definitions.
Where the Model Came From
The medical model’s roots in psychology trace back to the late 1800s and the work of German psychiatrist Emil Kraepelin. He was among the first physicians to argue that mental illness should be studied through close observation and careful description, the same methods used in the rest of medicine. Kraepelin grouped psychiatric disorders into categories based on their symptoms and outcomes, most notably distinguishing between what we now call schizophrenia and bipolar disorder. His insistence that whether a patient improved or worsened over time was itself a diagnostic clue laid the groundwork for modern psychiatric classification. By treating mental illness as something that could be systematically observed, categorized, and predicted, Kraepelin helped establish psychiatry as a clinical science.
Treatment Under the Medical Model
Because the model locates the problem in biology, its preferred treatments target biology. Medication is the primary tool. Antidepressants, antipsychotics, mood stabilizers, and anti-anxiety medications all aim to alter brain chemistry or neural activity in ways that reduce symptoms. The World Health Organization publishes guidance specifically to help primary care physicians prescribe these medications for conditions ranging from psychotic disorders and depression to bipolar disorder, anxiety, and substance dependence.
In more severe or treatment-resistant cases, the model also supports electroconvulsive therapy, which uses controlled electrical stimulation to trigger changes in brain chemistry, and in rare situations, surgical interventions. The through-line is always the same: if the problem is biological, the solution should be too.
Major Criticisms of the Model
The medical model has drawn sustained criticism since at least the 1960s. Psychiatrist Thomas Szasz famously challenged the very concept of mental illness, arguing that diagnostic labels medicalize what are really problems of living. Sociologist Thomas Scheff developed a formal labeling theory in 1966, proposing that once a person receives a psychiatric diagnosis, society’s reactions to that label create additional disturbance beyond whatever the original problem was.
The labeling concern has been extensively studied, with mixed results. Sociologist Walter Gove reviewed the evidence and concluded that labeling theory is “substantially invalid,” arguing that any social rejection directed at psychiatric patients stems from their behavior rather than from the diagnostic label itself. More methodologically rigorous studies have generally failed to find strong evidence that diagnoses alone stigmatize patients. That said, researchers acknowledge real problems with diagnostic practice: once a clinician reaches a diagnosis, confirmation bias can set in, leading them to interpret new information through the lens of the existing label and potentially miss important details.
The deeper criticism is philosophical. In a landmark 1977 paper, psychiatrist George Engel argued that the biomedical model “leaves no room within its framework for the social, psychological, and behavioral dimensions of illness.” It demands that all disease, including mental disease, be explained through disordered physical mechanisms. Engel pointed out that this couldn’t account for why two people with identical biology might experience the same condition very differently, or why one person experiences emotional reactions to life circumstances as an illness while another sees them as ordinary problems.
The Biopsychosocial Alternative
Engel proposed a broader framework called the biopsychosocial model, which treats biological factors as one piece of a larger picture that includes psychological patterns and social context. Under this approach, a clinician evaluating someone with depression wouldn’t just look at neurotransmitter levels or family history. They would also consider the person’s thought patterns, coping skills, relationships, economic stressors, and cultural background, then weigh how all of those factors interact.
The biopsychosocial model doesn’t reject biology. It rejects the idea that biology alone is sufficient. A person’s social environment, their interpretation of their own experiences, and the systems they live within all shape whether a biological vulnerability actually becomes an illness, and whether treatment succeeds. Most modern clinical training encourages some version of this integrated thinking, even as the medical model’s infrastructure (the DSM, insurance coding, prescription protocols) continues to dominate day-to-day practice.
In reality, many clinicians operate somewhere between the two models. A psychiatrist might prescribe medication to address the biological component of a condition while simultaneously referring the patient for talk therapy to address psychological and social factors. The medical model provides the diagnostic language and the pharmacological tools, while the biopsychosocial perspective reminds clinicians that a diagnosis is not the whole story.